< Back to latest news & events

Event

ONE Life Sciences Leadership Forum 6

September 2020

Event date: 1st September 2020

The sixth ONE Life Sciences Leadership Forum will explore intellectual property and clinical pathway strategies.

HGF Partner Craig Thomson, Senior Trade Mark Attorney Caroline Pigott and CEO of clinical trials management company Afortiori Development Nicola Wall will host the session, where they will investigate how to manage the complex and costly challenges of pursuing IP protection for your technology and growing brand, setting up a clinical pathway and secure marketing approval for the product.

This session will explore how to bring these challenges into a coordinated strategy specifically designed to support each other, as well as the broader commercial goals of your company, such as raising investment. It will also include an interactive discussion, work through a scenario based on real-life situations and guidance on how to apply the lessons learned.

Latest updates

Agritech Thymes: Arusha Protocol Enters into Force

Since being introduced in July 2015, the Arusha protocol for the protection of novel plant varieties in Africa has finally entered into force on the 24th November 2024, after ratification …

Read article

HGF office closures in December 2024 and January 2025

Please note that our offices will be closed for business in accordance with national holidays on the following dates.  Please plan accordingly and provide us with your instructions in advance …

Read article

Central Division takes pragmatic approach to late-filed submissions and revokes VMR’s patent for lack of inventive step

In Njoy v VMR (UPC_CFI_308/2023), the Paris Central Division confirmed that the “front loaded” provisions of the UPC should be interpreted in line with the principles of proportionality and procedural …

Read article

Celebrating Success – Director Promotions

We are proud to announce that 7 of our team have been promoted to director effective from 1 December 2024! These promotions recognise the outstanding contributions demonstrated by these individuals, who …

Read article

G2/24: A new referral to the Enlarged Board seeks to clarify whether a third party who intervened during appeal proceedings can acquire full appellant status

In the referring decision, T1286/23, the Board of Appeal referred the following questions to the Enlarged Board of Appeal: After the withdrawal of all appeals, may the proceedings be continued …

Read article

UPC first FRAND judgment results in injunction against OPPO

Panasonic Holdings Corporation v Guangdong OPPO Mobile Telecommunications Corp. Ltd & anor UPC_CFI_210/2023 – Mannheim Local Division (Tochtermann, Böttcher, Brinkman & Loibner) – 22 November 2024. The UPC issued its …

Read article